Indberetningsfrekvensen for rabdomyolyse stiger, når cerivastatin ordineres i doser på 0, 4 mg eller derover sammen med clopidogrel, sammenlignet med monoterapi.
There was an increase in the reporting rate of rhabdomyolysis when cerivastatin was prescribed at doses of 0.4mg or more with clopidogrel compared with monotherapy.